Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma

Fig. 3

Univariate and multivariate survival analysis of PFS and OS. (A-D) Forest plots showing hazard ratios for PFS and OS estimated by univariate and multivariate Cox proportional hazards regression outcome analyses. Forest plots showing the association between risk factors and survival in our center. ADA, Anti-drug antibodies; BCMA, B-cell maturation antigen; CAR, chimeric antigen receptor; CR, complete response; EMMR-ISS, Revised International Staging System; HR, hazard ratio; MRD, minimal residual disease; OS, overall survival; PFS, progression-free survival; SCT, stem cell transplantation; sBCMA, Plasma levels of soluble BCMA

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us